{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:21:12Z","timestamp":1793784072178,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-244x-10-43","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T18:58:21Z","timestamp":1276196301000},"source":"Crossref","is-referenced-by-count":98,"title":["Post-injection delirium\/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases"],"prefix":"10.1186","volume":"10","author":[{"given":"Holland C","family":"Detke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Sorsaburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J","family":"Stefaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A","family":"Corya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"673_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4088\/JCP.v69n0512","volume":"69","author":"J Lauriello","year":"2008","unstructured":"Lauriello J, Lambert T, Andersen SW, Lin DY, Taylor CC, McDonnell D: An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. J Clin Psychiatry. 2008, 69: 790-799. 10.4088\/JCP.v69n0512.","journal-title":"J Clin Psychiatry"},{"key":"673_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1176\/appi.ajp.2009.07081221","volume":"167","author":"JM Kane","year":"2010","unstructured":"Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell DP: Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry. 2010, 167: 181-189. 10.1176\/appi.ajp.2009.07081221.","journal-title":"Am J Psychiatry"},{"key":"673_CR3","volume-title":"Assessment report for Zypadhera","author":"European Medicines Agency","year":"2008","unstructured":"European Medicines Agency: Assessment report for Zypadhera. 2008, [\n                    http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/Zypadhera\/H-890-en6.pdf\n                    \n                  ]"},{"key":"673_CR4","volume-title":"Summary of product characteristics for ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection","author":"Electronic Medicines Compendium","year":"2009","unstructured":"Electronic Medicines Compendium: Summary of product characteristics for ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection. 2009, [\n                    http:\/\/emc.medicines.org.uk\/medicine\/21361\/SPC\/ZYPADHERA\n                    \n                  ]"},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-244X-10-45","volume":"10","author":"DP McDonnell","year":"2010","unstructured":"McDonnell DP, Detke HC, Kothare P, Johnson J, Stickelmeyer M, Sorsaburu S, Watson SB, Mitchell MI: Post-injection delirium\/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism. BMC Psychiatry. 2010, 10: 45-10.1186\/1471-244X-10-45.","journal-title":"BMC Psychiatry"},{"key":"673_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00007435-197801000-00002","volume":"5","author":"TF Downham","year":"1978","unstructured":"Downham TF, Cawley RA, Salley SO, Dal Santo G: Systemic toxic reactions to Procaine Penicillin G. Sex Transm Dis. 1978, 5: 4-9. 10.1097\/00007435-197801000-00002.","journal-title":"Sex Transm Dis"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2190\/KNQT-UEU4-GAQ2-57L6","volume":"16","author":"JL Cummings","year":"1986","unstructured":"Cummings JL, Barritt CF, Horan M: Delusions induced by procaine penicillin: case report and review of the syndrome. Int J Psychiatry Med. 1986, 16: 163-168. 10.2190\/KNQT-UEU4-GAQ2-57L6.","journal-title":"Int J Psychiatry Med"},{"key":"673_CR8","volume-title":"ISMP medication safety alert: Hazard warning","author":"Institute for Safe Medication Practices","year":"1997","unstructured":"Institute for Safe Medication Practices: ISMP medication safety alert: Hazard warning. 1997, [\n                    http:\/\/www.ismp.org\/Newsletters\/acutecare\/articles\/19970910.asp\n                    \n                  ]"},{"key":"673_CR9","volume-title":"ISMP medication safety alert: Many wrongly believe long-acting parenteral penicillins are for intravenous injection","author":"Institute for Safe Medication Practices","year":"1999","unstructured":"Institute for Safe Medication Practices: ISMP medication safety alert: Many wrongly believe long-acting parenteral penicillins are for intravenous injection. 1999, [\n                    http:\/\/www.ismp.org\/Newsletters\/acutecare\/articles\/19990630_2.asp\n                    \n                  ]"},{"key":"673_CR10","volume-title":"ISMP medication safety alert: Bicillin products: syringe enhancements may help to prevent IV administration","author":"Institute for Safe Medication Practices","year":"2004","unstructured":"Institute for Safe Medication Practices: ISMP medication safety alert: Bicillin products: syringe enhancements may help to prevent IV administration. 2004, [\n                    http:\/\/www.ismp.org\/Newsletters\/acutecare\/articles\/20040506_2.asp\n                    \n                  ]"},{"key":"673_CR11","first-page":"253","volume":"3","author":"M Do Carmo de Castro Miranda","year":"2004","unstructured":"Do Carmo de Castro Miranda M, Rozenfeld S, Pacheco de Oliveira S: A systemic review of the non-allergic adverse reactions following benzathine benzylpenicillin injection. J Vasc Bras. 2004, 3: 253-260.","journal-title":"J Vasc Bras"},{"key":"673_CR12","volume-title":"Septocaine with epinephrine [package insert]","author":"Novocol Pharmaceuticals of Canada, Inc","year":"2005","unstructured":"Novocol Pharmaceuticals of Canada, Inc: Septocaine with epinephrine [package insert]. 2005"},{"key":"673_CR13","volume-title":"ISMP medication safety alert: Action needed to prevent serious tissue injury with IV promethazine","author":"Institute for Safe Medication Practices","year":"2006","unstructured":"Institute for Safe Medication Practices: ISMP medication safety alert: Action needed to prevent serious tissue injury with IV promethazine. 2006, [\n                    http:\/\/www.ismp.org\/Newsletters\/acutecare\/articles\/20060810.asp\n                    \n                  ]"},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0025-6196(11)61533-4","volume":"80","author":"S Sen","year":"2005","unstructured":"Sen S, Chini EN, Brown MJ: Complications after unintentional intra-arterial injection of drugs: risks, outcomes and management strategies. Mayo Clin Proc. 2005, 80: 783-795. 10.4065\/80.6.783.","journal-title":"Mayo Clin Proc"},{"key":"673_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7326\/0003-4819-147-4-200708210-00021","volume":"147","author":"J Tang","year":"2007","unstructured":"Tang J, Weiter JJ: Branch retinal artery occlusion after injection of a long-acting risperidone preparation. Ann Intern Med. 2007, 147: 283-284.","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"673_CR16","first-page":"288S","volume":"63","author":"D Kurtz","year":"2008","unstructured":"Kurtz D, Bergstrom R, McDonnell DP, Mitchell M: Pharmacokinetics of multiple doses of olanzapine long-acting injection, an intramuscular formulation of olanzapine, in stabilized patients with schizophrenia [abstract]. Biol Psychiatry. 2008, 63 (suppl 1): 288S-","journal-title":"Biol Psychiatry"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.npp.1301409","volume":"33","author":"D Mamo","year":"2008","unstructured":"Mamo D, Kapur S, Keshavan M, Laruelle M, Taylor CC, Kothare PA, Barsoum P, McDonnell D: D2 Receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia. Neuropsychopharmacology. 2008, 33: 298-304. 10.1038\/sj.npp.1301409.","journal-title":"Neuropsychopharmacology"},{"issue":"suppl 4","key":"673_CR18","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1016\/S0924-977X(08)70638-2","volume":"18","author":"H Detke","year":"2008","unstructured":"Detke H, McDonnell D, Andersen S, Watson S: Olanzapine long-acting injection in patients with schizophrenia at risk of relapse: 12-week switching data [abstract]. European Neuropsychopharmacology. 2008, 18 (suppl 4): S435-10.1016\/S0924-977X(08)70638-2.","journal-title":"European Neuropsychopharmacology"},{"issue":"suppl 1","key":"673_CR19","first-page":"S151","volume":"11","author":"HC Detke","year":"2008","unstructured":"Detke HC, McDonnell DP, Andersen SW, Watson SB: 160-week interim results from an open-label extension trial of olanzapine long-acting injection [abstract]. International Journal of Neuropsychopharmacology. 2008, 11 (suppl 1): S151-","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"673_CR20","first-page":"37","volume":"3","author":"HG Goldsweig","year":"1976","unstructured":"Goldsweig HG, Kapusta M, Schwatz J: Bleeding, salicylates, and prolonged prothrombin time: three case reports and a review of the literature. J Rheumatol. 1976, 3: 37-42.","journal-title":"J Rheumatol"},{"key":"673_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0140-6736(67)91658-3","volume":"2","author":"HJ Weis","year":"1967","unstructured":"Weis HJ, Aledort LM: Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967, 2: 495-497. 10.1016\/S0140-6736(67)91658-3.","journal-title":"Lancet"},{"key":"673_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1172\/JCI105903","volume":"47","author":"HJ Weis","year":"1968","unstructured":"Weis HJ, Aledort LM, Kochwa S: The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968, 47: 2169-2180.","journal-title":"J Clin Invest"},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/01.alc.0000183011.86768.61","volume":"29","author":"KJ Mukamal","year":"2005","unstructured":"Mukamal KJ, Massaro JM, Ault KA, Mittleman MA, Sutherland PA, Lipinska I, Levy D, D'Agostino RB, Tofler GH: Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. Alcohol Clin Exp Res. 2005, 29: 1906-1912. 10.1097\/01.alc.0000183011.86768.61.","journal-title":"Alcohol Clin Exp Res"},{"key":"673_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1530-0277.1986.tb05167.x","volume":"10","author":"FL Iber","year":"1986","unstructured":"Iber FL, Shamszad M, Miller PA, Jacob R: Vitamin K deficiency in chronic alcoholic males. Alcohol Clin Exp Res. 1986, 10: 679-681. 10.1111\/j.1530-0277.1986.tb05167.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"673_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bmj.2.5649.89","volume":"2","author":"A Hart","year":"1969","unstructured":"Hart A, Cohen H: Capillary fragility studies in diabetes. Br Med J. 1969, 2: 89-91. 10.1136\/bmj.2.5649.89.","journal-title":"Br Med J"},{"key":"673_CR26","first-page":"93","volume":"45","author":"KR Purushothaman","year":"2007","unstructured":"Purushothaman KR, Meerarani P, Moreno PR: Inflammation and neovascularization in diabetic atherosclerosis. Indian J Exp Biol. 2007, 45: 93-102.","journal-title":"Indian J Exp Biol"},{"key":"673_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2307\/3464849","volume":"96","author":"SC Beyea","year":"1996","unstructured":"Beyea SC, Nicoll LH: Back to basics. Administering IM injections the right way. Am J Nurs. 1996, 96: 34-35. 10.2307\/3464849.","journal-title":"Am J Nurs"},{"key":"673_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7748\/ns1999.06.13.39.47.c2623","volume":"13","author":"B Workman","year":"1999","unstructured":"Workman B: Safe injection techniques. Nurs Stand. 1999, 13: 47-53.","journal-title":"Nurs Stand"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-10-43\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T06:38:20Z","timestamp":1548225500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-10-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-10-43","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]},"article-number":"43"}}